Common Contracts
5 similar Indemnification Agreement contracts by VistaGen Therapeutics, Inc., Xtent Inc, Biomira CORP
VISTAGEN THERAPEUTICS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • July 18th, 2013 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • California
THIS AGREEMENT is entered into, effective as of May 20, 2013 between VistaGen Therapeutics, Inc., a Nevada corporation (the "Company"), and H. Ralph Snodgrass, Ph. D. (“Indemnitee”).
VISTAGEN THERAPEUTICS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • July 18th, 2013 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • California
THIS AGREEMENT is entered into, effective as of May 20, 2013 between VistaGen Therapeutics, Inc., a Nevada corporation (the "Company"), and Brian J. Underdown, Ph. D. (“Indemnitee”).
ONCOTHYREON INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • September 27th, 2007 • Biomira CORP • Services-commercial physical & biological research • Delaware
THIS AGREEMENT is entered into, effective as of , 20 by and between Oncothyreon Inc., a Delaware corporation (the "Company"), and ("Indemnitee").
XTENT, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • September 8th, 2006 • Xtent Inc • Surgical & medical instruments & apparatus • Delaware
THIS AGREEMENT is entered into, effective as of , 2006 by and between Xtent, Inc., a Delaware corporation (the "Company"), and ("Indemnitee"), effective as of the date that the Registration Statement on Form S-1 related to the initial public offering of the Company's Common Stock is declared effective by the United States Securities and Exchange Commission.
XTENT, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • August 7th, 2006 • Xtent Inc • Delaware
THIS AGREEMENT is entered into, effective as of , 2006 by and between Xtent, Inc., a Delaware corporation (the "Company"), and ("Indemnitee"), effective as of the date that the Registration Statement on Form S-1 related to the initial public offering of the Company's Common Stock is declared effective by the United States Securities and Exchange Commission.
